This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2015 Remove Assay Development Remove DNA Related Topics
Immune Response Packaging Pharmaceuticals FDA Approval Treatment Drug Development Virus Vaccine Regulations Drugs More Related Topics >
article thumbnail

Ensuring reliable assays: Why the ideal microplate is an invisible one

Drug Discovery World

DECEMBER 14, 2023

Then Nexus was acquired by Brooks Automation and we were able to acquire the Aurora business in October 2015. But it comes with surface charge that will absorb proteins, DNA, and other things, unless you do something to treat that surface.

Laboratories 130
Laboratories Production Science Packaging 130
article thumbnail

The path to improved safety of gene-based products

Drug Discovery World

MAY 11, 2023

In addition, their cumbersome developmental process limits their use for fast-tracked new modalities, such as DNA-based vaccines. This approval could pave the way for LC-MS to transition more frequently into a good manufacturing process (GMP) environment, where it can be used as a release assay for regulatory documentation.

Production 130
Production Vaccine Immune Response Therapies 130
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 42,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024